Understanding the Barriers to Neoadjuvant Chemotherapy in Patients with Muscle Invasive Bladder Cancer: A Quality Improvement Initiative-Reference-Cited by-同舟云学术

Understanding the Barriers to Neoadjuvant Chemotherapy in Patients with Muscle Invasive Bladder Cancer: A Quality Improvement Initiative

Published:2021-03 Issue:2 Volume:8 Page:217-225
ISSN:2352-0779
Container-title:Urology Practice
language:en
Short-container-title:Urology Practice

Author:

Andino Juan J.¹,Sessine Michael²,Singhal Udit¹,Reichert Zachery R.³,Wray Daniel⁴,Shafer Christine¹,Moore Marissa¹,Weizer Alon Z.¹,Kaffenberger Samuel D.¹,Herrel Lindsey A.¹,Morgan Todd M.¹,Hafez Khaled Z.¹,Montgomery Jeffrey S.¹

Affiliation:

1. Department of Urology, Michigan Medicine; Ann Arbor, Michigan

2. University of Michigan Medical School; Ann Arbor, Michigan

3. Department of Internal Medicine, Division of Hematology and Oncology, Michigan Medicine; Ann Arbor, Michigan

4. Twine Clinical Consulting, LLC; Park City, Utah

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Social Vulnerability and Receipt of Neoadjuvant Chemotherapy in Patients Undergoing Radical Cystectomy for Bladder Cancer;Urology;2024-09

2. Utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in elderly patients: a retrospective cohort study;Medical Oncology;2024-07-09

3. Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle-Invasive Bladder Cancer: Elective and Eligibility Factors Impacting Utilization;Urology Practice;2024-01

4. The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomy;Canadian Urological Association Journal;2023-10-03

5. Comparative analysis of three vs. four cycles of neoadjuvant gemcitabine and cisplatin for muscle invasive bladder cancer;Urologic Oncology: Seminars and Original Investigations;2022-10